Channel Therapeutics Corporation

CHROAMEXHealthcare

$1.35

+$0.09(+7.14%)

Market Cap$8904398

P/E Ratio—

52W High$54.29

52W Low$1.2301

Avg Volume76K

Open$1.25

Beta3.29

Overview

Channel Therapeutics Corporation (CHRO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

chro · stock forecast · 1 analysts (3M) · FMP · updated Mar 26, 2026

Analyst Rating & Consensus

Based on 1 Wall Street analysts in the past 3 months

Buy

1 analysts

consensus

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

Total: 1 · Buy rate: 100.0%

12-Month Price Target

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $22.14

The Channel Therapeutics Corporation (CHRO) analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month CHRO price target is $0.00, representing +0.0% upside from the current price of $22.14.

Short-Term Price Prediction

Algorithmically generated · Updated daily

Date	Predicted Price	Change	Min	Max
2026-06-09	$22.14	↑ 0.00%	$21.69	$22.59

1-day model range: $21.69–$22.59. Peak: $22.59 (+0.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

29%71%0%

4Buy

10Neutral

0Sell

RSI (14)50.0Neutral

MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CHRO · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$21.70BUY

MA 10$21.21BUY

MA 20$0.00NEUTRAL

MA 50$0.00NEUTRAL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $CHRO · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$21.77BUY

EMA 10$21.59BUY

EMA 20$0.00NEUTRAL

EMA 50$0.00NEUTRAL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $CHRO · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:

Date	Brokerage	Action	Rating

Wall Street analysts have recently issued updated ratings on Channel Therapeutics Corporation (CHRO) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover CHRO.

Analyst Recommendation Trends

CHRO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$0M

Revenue Next Year

$17M

EPS This Year

$-1.30

EPS Next Year

$-1.10

↓ 15.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CHRO EPS of $-1.30 for the current fiscal year, based on estimates from 1 analysts. The CHRO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CHRO stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CHRO price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.

The CHRO short-term stock prediction for tomorrow is $22.14 (+0.00%).

Channel Therapeutics Corporation trades on AMEX under the ticker CHRO. The CHRO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Earnings Revenue PE Ratio Financials Market Cap Insider Trades Dividends Price History

Frequently asked questions

CHRO forecast · 8 questions

According to 1 Wall Street analysts, the average 12-month CHRO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $22.14.

CHRO price targetWhat is CHRO price targetCHRO analyst price targetCHRO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.